Physician profile
Kelly L Wright
NPI 1710959317
$1,250.71
in general payments reported to CMS, 2019-2025
11 companies · $338 in 2025
The $338 reported for 2025 was more than what a typical Surgical provider received nationally (typical 2025 total: $146).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $352 · 2022: $109 · 2023: $208 · 2024: $244 · 2025: $338.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $790.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $790.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $334.05 | 2021 | |
| Idorsia Pharmaceuticals US INC | $230.63 | 2022-2023 | Quviviq |
| Depuy Synthes Sales INC. | $166.02 | 2024-2025 | |
| Astrazeneca Pharmaceuticals LP | $122.17 | 2025 | Wainua |
| Axsome Therapeutics, INC. | $100.52 | 2025 | Symbravo |
| Bioventus LLC | $86.59 | 2023 | Exogen Ultrasound Bone Healing System |
| Neurelis, INC. | $81.30 | 2024 | Valtoco |
| Inspire Medical Systems, INC. | $77.47 | 2025 | Inspire |
| Vertex Pharmaceuticals Incorporated | $19.40 | 2025 | |
| W. L. Gore & Associates, INC. | $17.61 | 2021 | |
| Ethicon US, LLC | $14.95 | 2024 | Stratafix |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kelly Wright listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.